echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > 6 varieties of more than 1 billion proprietary Chinese medicines lead the way and 38 exclusive varieties dominate the screen

    6 varieties of more than 1 billion proprietary Chinese medicines lead the way and 38 exclusive varieties dominate the screen

    • Last Update: 2022-12-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, the State Administration of Traditional Chinese Medicine issued the "Guidelines for Home Medicine Intervention for People Infected with the New Coronavirus Infection", and 60 proprietary Chinese medicines (38 exclusive varieties) were recommended
    .
    According to data from Minai.
    com, the total sales scale of 60 proprietary Chinese medicines in China's three major terminal markets in 2021 exceeded 24.
    5 billion yuan, and the sales of 6 varieties exceeded 1 billion yuan
    .
    Among the 38 exclusive varieties, Yangzijiang, Kangyuan and Yiling each have 3 varieties listed, and Sinopharm Group and Beijing Tongrentang each have 2 varieties on the list
    .
     
    Authoritative release by the National Health Commission and the Bureau of Traditional Chinese Medicine! Proprietary Chinese medicines are very popular
     
    With the mutation of the new crown virus and the changes in the global epidemic, the joint prevention and control mechanism of the State Council has successively issued 20 measures for epidemic prevention and control and 10 new measures, promoting China's epidemic prevention and control into a new stage
    .
     
    With the adjustment and optimization of new crown epidemic prevention policies in many places in China, the country has entered a new period of epidemic home prevention and control, and the market demand for new crown virus prevention and control drugs has increased sharply, and there has been a crazy wave of drug purchases in many places
    .
     
    On December 8, the joint prevention and control mechanism of the State Council issued the "Reference Table of Common Drugs for Home Treatment of Persons Infected with New Coronavirus Infection", which lists commonly used drugs according to seven symptoms of fever, dry throat soreness, cough and phlegm, dry cough without phlegm, runny nose, nasal congestion, and nausea/vomiting, and 8 proprietary Chinese medicines, including Jinhua Qinggan granules, Lianhua Qingwen granules/capsules, Xuanlung sepsis granules, lung cleansing and detoxification granules, Shufeng detoxification capsules, Liushen pills, Qingxing drop pills, and Huoxiang zhengqi water/capsules, are on the list
    .
     
    Reference table of commonly used drugs
     
    On December 10, the State Administration of Traditional Chinese Medicine officially issued the Guidelines for Home Medicine Intervention for People Infected with the New Coronavirus (the Guidelines), which provides guidance
    for people to take drugs at home.
    The guidelines respectively put forward corresponding proprietary Chinese medicine treatment and dosing plans for adults, children and special groups infected with the new coronavirus, and announced the prevention and rehabilitation drug plans
    .
    59 kinds of proprietary Chinese medicines were listed as recommended drugs for the treatment of adults and children, and jade screen granules were listed as preventive drugs, which aroused great concern and discussion
    in the market.
     
    According to the author's statistics, the 60 proprietary Chinese medicines recommended by the Guidelines involve 38 exclusive varieties
    .
    According to data from Minai.
    com, the total sales scale of 60 proprietary Chinese medicines in China's three major terminal markets in 2021 (see the end of this article for statistical scope) exceeded 24.
    5 billion yuan
    .
    As a preventive medicine, Yupingfeng granules are a well-known proprietary Chinese medicine, an exclusive variety of Sinopharm, with sales of more than 400 million yuan in China's three major terminal markets in 2021
    .
     
    29 exclusive proprietary Chinese medicines! Yangtze River, Yiling and Kang Yuan lead
     
    The Guidelines suggest five symptoms in the treatment plan for adults, including fever, chills, muscle aches, dry throat, fatigue, nasal congestion, runny nose, or cough; Symptoms include obvious sore throat, fever, muscle aches, fatigue, or cough; Symptoms are obvious cough; Symptoms include fatigue, accompanied by gastrointestinal discomfort, such as vomiting, diarrhea; The symptoms were obvious nasal congestion and runny nose, involving a total of 45 proprietary Chinese medicines
    .
    Among them, Lianhua cough tablets are recommended for symptoms 2 and 3
    .
     
    Adult treatment regimen of proprietary medicines
     
    Among the recommended drugs for adult treatment, 9 proprietary Chinese medicines, such as Shufeng Detoxification Capsules (granules), Cold Shufeng Capsules (tablets, granules), Liushen Pills (capsules), Tongxuanli Lung Pills (granules, oral liquid), and Huoxiang Zhengqi Capsules (pills, water, oral liquid), involve 2 or more dosage forms, so 45 proprietary Chinese medicines specifically involve 57 types of proprietary Chinese
    medicines.
     
    Among the 57 proprietary Chinese medicines, 8 varieties have more than 100 enterprises with approvals, including cold clear heat granules, mulberry ju cold tablets, Xia mulberry ju granules, cold antipyretic granules, Tongxuanli lung pills, Huo Xiang zhengqi pills, Huo Xiang zhengqi water, and windproof Tongsheng pills
    .
    Among them, cold antipyretic granules led by 194 manufacturers, Huo Xiang Zhengqi Water had 162 manufacturers, Tongxuanli lung pills and Huo Xiang zhengqi pills had 142 and 143 respectively
    .
     
    29 proprietary Chinese medicines are exclusive varieties, including Darentang's Clear Throat Drop Pill, Zhenbao Island's Compound Qianlan Oral Liquid, Guizhou Bailing's Cough Quick-Stop Syrup, Xiangxue Pharmaceutical's Orange Red Phlegm Cough Liquid, Taiji Group's Sinusitis Oral Liquid, etc
    .
    It is worth mentioning that Yangzijiang Pharmaceutical has 3 exclusive varieties of Lanqin oral liquid, Chaiqian Qingning capsules and scattered wind tongjiao drop pills on the list, Yiling Pharmaceutical has 3 exclusive varieties of Lianhua Qingwen capsules, Lianhua Qingwen granules and Lianhua cough tablets, and Kangyuan Pharmaceutical has 2 exclusive varieties of dispersing cold wet granules and apricot shell cough granules on the list
    .
     
    According to data from Minai.
    com, the total sales scale of 57 proprietary Chinese medicines in China's three major terminal markets in 2021 exceeded 18.
    3 billion yuan
    .
    Among them, the sales of 27 proprietary Chinese medicines exceeded 100 million yuan, the sales of 5 varieties exceeded 1 billion yuan, Yangzijiang Pharmaceutical's Lanqin oral liquid led with sales of more than 2.
    5 billion yuan, the sales of Lianhua Qingwen capsules and Lianhua Qingwen granules of Yiling Pharmaceutical exceeded 2.
    3 billion yuan, the sales of Huoxiang zhengqi oral liquid exceeded 1.
    8 billion yuan, and the sales of double huanglian oral liquid exceeded 1.
    2 billion yuan.

     
    14 proprietary Chinese medicines for children! Jichuan, Kang Yuan, Sanli.
    .
    .
    8 exclusive varieties on the list
     
    The Guidelines suggest six types of symptoms in the treatment plan for children, including those with chills, fever and muscle aches; Symptoms include fever, dry throat, sore throat, cough; Symptoms include fever, less food and bloating, bad breath, sour stools or constipation; The symptoms are obvious sore throat; Symptoms are obvious cough; The symptoms were fatigue and poor food, involving a total of 14 children's proprietary Chinese medicines
    .
     
    Proprietary Chinese medicine in children's treatment programs
     
    From the perspective of the number of manufacturers, the competition for children's cough syrup is the most fierce, involving China Resources Sanjiu, Sunflower Pharmaceutical.
    .
    .
    There are 180 enterprises, including 21 children's throat clear granules, 17 children's clear solution, and 15 children's lung clearing cough tablets
    .
    It is worth mentioning that Pediatric Wind Heat Clear Oral Liquid was previously the exclusive variety of Handan Pharmaceutical, and in 2017, Handan Pharmaceutical applied to the State Food and Drug Administration for cancellation approval and was approved
    .
     
    Eight children's proprietary Chinese medicines are exclusive varieties, including Jinzhen oral liquid from Kangyuan Pharmaceutical, children's lung clearing oral liquid from Beijing Tongrentang, Pediatric Cough Suppression Oral Liquid from Lunan Houpu Pharmaceutical, Odor-reducing Pediatric Phlegm Dispersion from Zhejiang Dade Pharmaceutical, Pediatric Pediatric Heat Removal Granules from Jichuan Pharmaceutical, Throat Open Throat Sword Spray (Children's Type) from Sanli Pharmaceutical, Qingxuan Cough Relief Granules from Suzhong Pharmaceutical, and Spleen Raising Granules
    from Guizhou Jianxing Pharmaceutical.
     
    According to data from Minai.
    com, the total sales scale of 14 children's proprietary Chinese medicines in China's three major terminal markets in 2021 exceeded 5.
    7 billion yuan, of which 9 children's
    proprietary Chinese medicines had sales of more than 100 million yuan.
    Exclusive varieties led the way, with sales of pediatric soy Qingqiao heat granules of Jichuan Pharmaceutical exceeding 1.
    9 billion yuan, Sanli Pharmaceutical's open-throat sword spray (children's type) sales exceeding 900 million yuan, Kangyuan Pharmaceutical's Jinzhen oral liquid sales of nearly 900 million yuan, and Lunan Houpu Pharmaceutical's pediatric cough suppressant oral liquid sales exceeding 600 million yuan
    .
     
    Source: Minai.
    com database, State Administration of Traditional Chinese Medicine Note: Minai.
    com "China's three major terminal six major markets drug competition pattern", the statistical scope is: urban public hospitals and county-level public hospitals, urban community centers and township health centers, urban physical pharmacies and online pharmacies, excluding private hospitals, private clinics, village clinics, excluding county and rural pharmacies; The above sales are calculated
    based on the average retail price of the product at the terminal.
    If there is any omission in the data statistics, welcome to correct!
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.